EurekaMag
+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

List of PDF Full Texts available from EurekaMag Chapter 68041

Chapter 68041 contains a list of PDF Full Texts available from EurekaMag.




Blood Lactate Measurement in Recovery as an Adjunct to Training
, Sports Medicine 16(1): 5-13 (1993)

Effects of Altitude on Mood, Behaviour and Cognitive Functioning
, Sports Medicine 16(2): 97-125 (1993)

Energetics of Competitive Swimming
, Sports Medicine 18(6): 384-405 (1994)

Carbohydrate Ingestion/Supplementation for Resistance Exercise and Training
, Sports Medicine 21(1): 7-17 (1996)

Significance of the Velocity at VO2maxand Time to Exhaustion at this Velocity
, Sports Medicine 22(2): 90-108 (1996)

The Scientific Basis for High-Intensity Interval Training
, Sports Medicine 32(1): 53-73 (2002)

Diagnosis of Overtraining
, Sports Medicine 32(2): 95-102 (2002)

Growth Hormone Release During Acute and Chronic Aerobic and Resistance Exercise
, Sports Medicine 32(15): 987-1004 (2002)

Secular Trends in the Performance of Children and Adolescents (19802000)
, Sports Medicine 33(4): 285-300 (2003)

Heat Illness in Athletes
, Sports Medicine 34(1): 9-16 (2004)

The History of the Marathon
, Sports Medicine 37(4-5): 284-287 (2007)

The Evolution of Marathon Running
, Sports Medicine 37(4-5): 288-290 (2007)

Marathon Medical Support Historical Perspectives
, Sports Medicine 37(4-5): 291-293 (2007)

Running Economy
, Sports Medicine 37(4-5): 316-319 (2007)

Lactate
, Sports Medicine 37(4-5): 341-343 (2007)

Nutrition Strategies for the Marathon
, Sports Medicine 37(4-5): 344-347 (2007)

Muscle Cramping in the Marathon
, Sports Medicine 37(4-5): 364-367 (2007)

Blood Doping
, Sports Medicine 37(4-5): 389-391 (2007)

Heat and Cold
, Sports Medicine 37(4-5): 396-399 (2007)

The Psychology of the Marathoner
, Sports Medicine 37(4-5): 404-407 (2007)

Monitoring and Titrating Symptoms
, Sports Medicine 37(4-5): 408-411 ( 2007)

Strategies to Enhance Immune Function for Marathon Runners
, Sports Medicine 37(4-5): 416-419 (2007)

Genotypes and Distance Running
, Sports Medicine 37(4-5): 424-427 (2007)

Intravenous Fluids Post Marathon
, Sports Medicine 37(4-5): 434-436 (2007)

Cardiovascular Adaptations to Marathon Running
, Sports Medicine 37(4-5): 444-447 (2007)

Marathon Cardiac Deaths
, Sports Medicine 37(4-5): 448-450 (2007)

Hydration in the Marathon
, Sports Medicine 37(4-5): 463-466 (2007)

Dispensing Physicians and Prescribing Pharmacists
, PharmacoEconomics 5(1): 8-17 (1994)

The New Zealand Preferred Medicines Concept
, PharmacoEconomics 6(1): 5-14 (1994)

The Burden of Migraine
, PharmacoEconomics 6(3): 215-221 (1994)

Necessity of Using Intermediate Outcomes to Proxy Long Term Effects
, PharmacoEconomics 7(1): 7-13 (1995)

Preventing Nsaid-Induced Gastrointestinal Toxicity
, PharmacoEconomics 7(2): 99-110 (1995)

Economic Evaluation of Vaccination
, PharmacoEconomics 9(3 Suppl): 8-15 (1996)

The Cost of Alzheimers Disease
, PharmacoEconomics 9(1): 5-10 (1996)

Methadone Programmes
, PharmacoEconomics 10(4): 321-326 (1996)

Healthcare Resource Consumption in Terminal Care
, PharmacoEconomics 11(1): 2-12 (1997)

Cost-Utility Analysis of Melphalan plus Prednisone With or Without Interferon-2b in Newly Diagnosed Multiple Myeloma
, PharmacoEconomics 12(1): 89-103 (1997)

The Us Orphan Drug Programme
, PharmacoEconomics 12(3): 312-326 (1997)

Risperidone
, PharmacoEconomics 14(1): 97-133 (1998)

Donepezil
, PharmacoEconomics 16(1): 99-114 (1999)

Economic Cost of Male Erectile Dysfunction Using a Decision Analytic Model
, PharmacoEconomics 17(1): 77-107 (2000)

Antiviral Therapies for Herpes Zoster Infections
, PharmacoEconomics 18(2): 95-104 (2000)

Economic Evaluations of Influenza Vaccination in Healthy Working-Age Adults
, PharmacoEconomics 18(2): 173-183 (2000)

Enteroviral Meningitis
, PharmacoEconomics 19(1): 3-12 (2001)

Economic Analysis of Initial Hiv Treatment
, PharmacoEconomics 19(1): 95-104 (2001)

Which Antifungal Agent for Onychomycosis?
, PharmacoEconomics 19(10): 983-1002 (2001)

Pharmacy Benefit Management
, PharmacoEconomics 20(1): 9-21 (2002)

Cost-Effectiveness Analysis of Stratified Versus Stepped Care Strategies for Acute Treatment of Migraine
, PharmacoEconomics 20(2): 91-100 (2002)

Insulin Lispro
, PharmacoEconomics 20(14): 989-1025 (2002)

Cost-effectiveness league tables
, PharmacoEconomics 21(14): 991-1000 (2003)

Cost of Stress Urinary Incontinence
, PharmacoEconomics 22(2): 95-105 (2004)

Resource Use and Cost of Care for Patients Hospitalised with Community Acquired Pneumonia
, PharmacoEconomics 22(11): 751-757 (2004)

Use and cost of antiretrovirals in France 19952000
, PharmacoEconomics 22(16): 1061-1070 (2004)

Pharmacological management of overactive bladder
, PharmacoEconomics 23(10): 995-1006 (2005)

Trends in Outpatient Prescription Drug Use and Related Costs in the Us
, PharmacoEconomics 24(3): 233-236 (2006)

Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer
, PharmacoEconomics 24(5): 443-452 (2006)

Reducing the Societal Burden of Depression
, PharmacoEconomics 25(1): 7-24 (2007)

Measuring Preferences for Cost-Utility Analysis
, PharmacoEconomics 25(2): 93-106 (2007)

Its Time to Choose the Study Design!
, PharmacoEconomics 25(11): 903-911 (2007)

Nice Cost-Effectiveness Appraisal of Cholinesterase Inhibitors
, PharmacoEconomics 25(12): 997-1006 (2007)

The Last Decade of Italian Pharmaceutical Policy
, PharmacoEconomics 26(1): 5-15 (2008)

Management of Anaemia
, PharmacoEconomics 26(2): 99-120 (2008)